WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
0
%
0,00%
Latest
0.57
High
0.57
Low
0.544
Volume
141 527
Turnover (SEK)
79 544
Value (MSEK)
75,9

Board

CEO

  • Anders Rabbe

Chairperson of the Board

  • Gudrun Anstrén

Board

  • Bengt Gustavsson
  • Jan Nilsson
  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 10,68 10,68 2021-09-30
Nordnet Pensionsförsäkring 4,89 4,89 2021-09-30
Linfan Zhang 4,89 4,89 2021-09-30
Gunvald Berger 2,05 2,05 2021-09-30
Youplus Assurance AG 1,73 1,73 2021-09-30
Thomas Mellqvist 1,52 1,52 2021-09-30
Kjell Stenberg 1,51 1,51 2021-09-30
Lars-Erik Forsgårdh 1,19 1,19 2021-09-30
Niclas Evertsson 1,16 1,16 2021-09-30
Claes Sjölund 1,14 1,14 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-11-18 Delårsrapport 2021-Q3

  • 2022-02-24 Bokslutskommuniké 2021